No. |
著者名 |
演題名 |
掲載誌名 |
号 |
ページ |
年 |
1 |
Reddy RC, Chen GH, Newstead MW, Moore T, Zeng X, Tateda K and Standiford TJ |
Alveolar macrophage deactivation in murine septic peritonitis:Role of interleukin 10 |
Infect Immun |
69 |
1394-1401 |
2001 |
2 |
Tateda K, Moore TA, Deng JC, Newstead MW, Zeng X, Matsukawa A, Swanson MS, Yamaguchi K and Standiford TJ |
Early recruitment of neutrophils determines subsequent T1/T2 host responses in a murine model of Legionella pneumophila |
J Immunol |
166 |
3355-3361 |
2001 |
3 |
Miyazaki S, Hosoyama T, Furuya N, Ishii Y, Matsumoto T, Ohno A, Tateda K and Yamaguchi K |
In vitro and in vivo antibacterial activities of L-084, a novel oral carbapenem, against causative organisms of respiratory tract infections |
Antimicrob Agents Chemother |
45 |
203-207 |
2001 |
4 |
Yamaguchi K |
Evaluation of in-vitro and in-vivo antibacterial activity of tosufloxacin tosilate |
J Infect Chemother |
7 |
205-217 |
2001 |
5 |
Miyazaki S, Fujikawa T, Kanazawa K and Yamaguchi K |
In vitro and in vivo activities of meropenem and comparable antimicrobial agents against Haemophilus influenzae, including β-lactamase-negative ampicillin-resistant strains |
J Antimicrob Chemother |
48 |
723-726 |
2001 |
6 |
Miyazaki S, Fujikawa T, Kobayashi I, Matsumoto T, Tateda K and Yamaguchi K |
Development of systemic bacteraemia after oral inoculation of vancomycin-resistant enterococci in mice |
J Med Microbiol |
50 |
695-701 |
2001 |
7 |
Miyazaki S, Fujikawa T, Matsumoto T, Tateda K and Yamaguchi K |
Efficacy of azithromycin, clarithromycin and β-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice |
J Antimicrob Chemother |
48 |
425-430 |
2001 |
8 |
Miyazaki S, Nunoya T, Matsumoto T, Furuya N, Tateda K and Yamaguchi K |
Lipoolygosaccharide indirectly enhances inflammatory lesions in lungs as a primary infection site by non-encapsulated and type B Haemophilus influenzae through production of cytokines |
Cytokine |
15 |
171-174 |
2001 |
9 |
Miyazaki S, Tateda K, Matsumoto T, Ohno A, Ishii Y, Furuya N and Yamaguchi K |
In vitro antimicrobial activities of a novel everninomicin for multiple drug-resistant Streptococcus pneumoniae isolates in Japan |
J Antimicrob Chemother |
47 |
900-901 |
2001 |
10 |
Tateda K, Comte R, Pechere JC, Kohler T, Yamaguchi K and Van Delden C |
Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa |
Antimicrob Agents Chemother |
45 |
1930-1933 |
2001 |
11 |
Tateda K, Moore TA, Newstead MW, Tsai WC, Zeng X, Deng JC, Chen G, Reddy R, Yamaguchi K and Standiford TJ |
Chemokine-dependent neutrophil recruitment in a murine model of Legionella pneumonia: potential role of neutrophils as immunoregulatory cells |
Infect Immun |
69 |
2017-2024 |
2001 |
12 |
Okamoto H, Miyazaki S, Tateda K, Ishii Y and Yamaguchi K |
In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae |
Antimicrob Agents Chemother |
45 |
3250-3252 |
2001 |
13 |
Yoshida K, Matsumoto T, Tateda K, Uchida K, Tsujimoto S, Iwakurai Y and Yamaguchi K |
Protection against pulmonary infection with Klebsiella pneumoniae in mice by interferon-gamma through activation of phagocytic cells and stimulation of production of other cytokines |
J Med Microbiol |
50 |
959-964 |
2001 |
14 |
Yoshida K, Matsumoto T, Tateda K, Uchida K, Tsujimoto S and Yamaguchi K |
Induction of interleukin-10 and down-regulation of cytokine production by Klebsiella pneumoniae capsule in mice with pulmonary infection |
J Med Microbiol |
50 |
456-461 |
2001 |
15 |
Yoshizumi S, Takahashi Y, Murata M, Domon H, Furuya N, Ishii Y, Matsumoto T, Ohno A, Tateda K, Miyazaki S and Yamaguchi K |
The in vivo activity of olamufloxacin (HSR-903) in systemic and urinary tract infections in mice |
J Antimicrob Chemother |
48 |
137-140 |
2001 |
16 |
Kumasaka K, Kawano K, Yamaguchi K, Igari J, Minowa K, Oishi H and Morozumi S |
A study of quality assessment in clinical microbiology performance of independent laboratories in Tokyo: 18-year participation in the Tokyo Metropolitan Government External Quality Assessment Program |
J Infect Chemother |
7 |
102-109 |
2001 |
17 |
Reddy RC, Chen GH, Tateda K, Tsai WC, Phare SM, Mancuso P, Peters-Golden M and Standiford TJ |
Selective inhibition of COX-2 improves early survival in murine endotoxemia but not in bacterial peritonitis |
Am J. Physiol Lung Cell Mol Physiol |
281 |
L537-543 |
2001 |
18 |
Deng JC, Tateda K, Zeng X and Standiford TJ |
Transient transgenic expression of gamma interferon promotes Legionella pneumophila clearance in immunocompetent hosts |
Infect Immun |
69 |
6382-6390 |
2001 |